Skip to content
Alivexis, Inc.

Alivexis, Inc.

Unveiling the Future of Medicine

Menu

  • Home
  • Science
  • Pipeline
  • About Us
  • News
  • Public Notice
  • Contact Us
  • 日本語

Archives

Category: Press Releases

Modulus Discovery Announces the Appointment of Taka Koda, as Vice President, Corporate Planning

News - 
01 May, 2017 - 
Modulus Discovery, Inc., an early stage global biopharmaceutical company in Tokyo, Japan, announced today the appointment of Taka Koda, as Vice President, Corporate Planning. Mr. Koda joins us as a consultant from TK Venture Partners, Inc. and will be in charge of finance and corporate matters at Modulus. Mr. Koda has over 12 years experiences
...continued
Previous

Press & Media Contact

Latest Release

  • Alivexis to Present at ACS Spring Conference
  • Alivexis Announces Notice of U.S. Patent Registration for Novel Cathepsin C Inhibitor
  • Alivexis and OHARA Pharmaceutical Co., Ltd. to Collaborate on Selected Drug Targets
  • Alivexis Announces Receipt of Intention to Exercise Option Right from Astellas Pharma Inc. for Collaboration on Novel Drug Target
  • Notice of Selection for the Ministry of Economy, Trade and Industry’s Domestic Generative AI Development Strengthening Project “GENIAC”
  • LinkedIn

 (c) Copyright 2026, Alivexis, Inc.
Privacy Policy Terms of Use

Copyright © 2026 Alivexis, Inc.. All rights reserved. Theme Spacious by ThemeGrill. Powered by: WordPress.